Results 231 to 240 of about 165,861 (406)

Paradoxical Efficacy With Rare Adverse Events: Sequential ALK Inhibitor Therapy in Lung Adenocarcinoma

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Anaplastic lymphoma kinase (ALK) inhibitors have markedly improved outcomes in ALK‐positive nonsmall‐cell lung cancer (NSCLC). While their efficacy is well documented, rare or organ‐specific toxicities remain underreported, limiting clinicians' ability to anticipate and manage adverse events during treatment or rechallenge with tyrosine kinase
Kang Xie, Nie Xu
wiley   +1 more source

Scrotal Abscess Mimicking Fixed Drug Eruption Under Ibuprofen Therapy: A Diagnostic Pitfall

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Concurrent NSAID therapy can pharmacologically mask early scrotal abscess, generating a presentation that fulfills clinical and historical criteria for fixed drug eruption. Ibuprofen simultaneously acts as a recognized causative agent and suppresses infectious inflammatory signs.
Youssef Maachi   +6 more
wiley   +1 more source

Medicare Part D and Hospital Admissions due to Antimicrobial Resistance

open access: yesHealth Economics, Volume 35, Issue 5, Page 759-777, May 2026.
ABSTRACT Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under‐utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage ...
Ricardo B. Ang III
wiley   +1 more source

Home - About - Disclaimer - Privacy